Kwality Pharmaceuticals concludes regulatory audit for Zimbabwe

This marks yet another milestone in our series of successful audits over the past year

Kwality Pharmaceuticals Ltd. (KPL) has successfully concluded a regulatory audit for Zimbabwe across its General, Beta-Lactam, Cephalosporin and Oncology units, with no critical observations. This marks yet another milestone in our series of successful audits over the past year.

This achievement underscores our unwavering commitment to quality, regulatory compliance, and operational excellence. It also strengthens our footprint in the ZAZIBONA region, paving the way for expansion and new strategic partnerships across Southern Africa.